Charles River Laboratories International, Inc.
USD179.87
+5.08 (+2.91%)
CEO
James C. Foster
IPO Date
2000-06-23
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Exchange
NYSE
Country
US
Open
$171.00
Prev. Close
$174.79
Day Low
$169.51
Day High
$180.75
52W Low
$138.81
52W High
$228.88
Market Cap
$8.66B
Volume
0.44M
| 921.1 |
| 28 Dec 2024 | FY | 32.9% | 0.3% | 0.3% | 0.1% | 0.79 | 1.41 | 928.9 |
| 30 Dec 2023 | FY | 36.4% | 11.5% | 13.2% | 5.8% | 0.85 | 1.52 | 25.5 |
| 31 Dec 2022 | FY | 36.8% | 12.2% | 16.3% | 6.4% | 1.06 | 1.32 | 22.8 |
| 25 Dec 2021 | FY | 37.7% | 11.0% | 15.4% | 5.6% | 1.15 | 1.23 | 47.5 |
| 26 Dec 2020 | FY | 36.7% | 12.5% | 17.2% | 6.6% | 1.01 | 1.43 | 34.2 |
| 28 Dec 2019 | FY | 36.6% | 9.6% | 15.4% | 5.4% | 1.23 | 1.44 | 29.4 |
| 29 Dec 2018 | FY | 37.1% | 10.0% | 17.2% | 5.9% | 1.27 | 1.61 | 23.7 |
| 30 Dec 2017 | FY | 37.8% | 6.6% | 11.8% | 4.2% | 1.10 | 1.78 | 42.1 |
| 33.6 |
| 28 Jun 2025 | Q2 | 34.6% | 5.1% | 1.6% | 0.7% | 0.83 | 1.36 | 35.2 |
| 29 Mar 2025 | Q1 | 32.3% | 2.6% | 0.8% | 0.3% | 0.93 | 1.43 | 77.4 |
| 28 Dec 2024 | Q4 | 28.4% | -21.5% | -6.2% | -2.9% | 0.79 | 1.41 | -11.0 |
| 28 Sept 2024 | Q3 | 34.6% | 6.8% | 1.8% | 0.9% | 0.73 | 1.48 | 37.1 |
| 29 Jun 2024 | Q2 | 32.7% | 8.8% | 2.4% | 1.1% | 0.76 | 1.58 | 29.6 |
| 30 Mar 2024 | Q1 | 31.7% | 6.7% | 1.8% | 0.8% | 0.72 | 1.75 | 51.7 |
| 30 Dec 2023 | Q4 | 35.9% | 18.5% | 5.2% | 2.3% | 0.98 | 1.52 | 16.2 |
| 30 Sept 2023 | Q3 | 35.2% | 8.5% | 2.6% | 1.1% | 1.01 | 1.45 | 28.8 |